Asia Vital Components (3017) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2024 reached NT$23.33 billion, up 52% year-over-year, with net income at NT$3.51 billion, a 101% increase from Q1 2023.

• Gross margin improved to 26% from 22% year-over-year, and basic EPS rose to NT$8.28 from NT$4.08.

• Cash and cash equivalents at quarter-end were NT$34.49 billion, up from NT$28.84 billion a year ago.

Financial highlights

• Operating income for Q1 2024 was NT$4.36 billion, up 125% year-over-year.

• Operating expenses increased to NT$1.67 billion, representing 7% of revenue.

• Net cash from operating activities was NT$5.71 billion, up from NT$3.83 billion year-over-year.

• Total assets grew to NT$111.82 billion, a 50% increase from Q1 2023.

• Total liabilities rose to NT$78.47 billion, up from NT$49.56 billion year-over-year.

Outlook and guidance

• Board approved a cash dividend of NT$7 per share for 2023, with an additional NT$3 per share from capital surplus.

• Company continues to invest in capacity expansion and R&D to support future growth.